TRIF antibody [C3], C-term
GTX104744
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
TargetTICAM1
Overview
- SupplierGeneTex
- Product NameTRIF antibody [C3], C-term
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1.01 mg/ml
- ConjugateUnconjugated
- Gene ID148022
- Target nameTICAM1
- Target descriptionTIR domain containing adaptor molecule 1
- Target synonymsIIAE6, MyD88-3, PRVTIRB, TICAM-1, TRIF, TIR domain-containing adapter molecule 1, TIR domain containing adaptor inducing interferon-beta, TIR domain-containing adapter protein inducing IFN-beta, proline-rich, vinculin and TIR domain-containing protein B, putative NF-kappa-B-activating protein 502H, toll like receptor adaptor molecule 1, toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta
- HostRabbit
- IsotypeIgG
- Protein IDQ8IUC6
- Protein NameTIR domain-containing adapter molecule 1
- Scientific DescriptionTRIF, or TICAM1, is a Toll/IL1R (MIM 147810) (TIR) domain-containing adaptor molecule, like MYD88 (MIM 602170) and TIRAP (MIM 606252), that induces interferon-beta (IFNB; MIM 147640), specifically interacts with TLR3 (MIM 603029), and activates nuclear factor kappa-B (NFKB; see MIM 164011).[supplied by OMIM]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- TLR4-Mediated Pathway Triggers Interferon-Independent G0 Arrest and Antiviral SAMHD1 Activity in Macrophages. Mlcochova P et al., 2020 Mar 24, Cell RepRead more





